These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 30587666)

  • 21. Effects of resistant starch type III polymorphs on human colon microbiota and short chain fatty acids in human gut models.
    Lesmes U; Beards EJ; Gibson GR; Tuohy KM; Shimoni E
    J Agric Food Chem; 2008 Jul; 56(13):5415-21. PubMed ID: 18543927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation.
    Tian DD; Xu XQ; Peng Q; Zhang YW; Zhang PB; Qiao Y; Shi B
    J Food Sci; 2020 Aug; 85(8):2554-2564. PubMed ID: 32677055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions.
    Upadhyaya B; McCormack L; Fardin-Kia AR; Juenemann R; Nichenametla S; Clapper J; Specker B; Dey M
    Sci Rep; 2016 Jun; 6():28797. PubMed ID: 27356770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metagenomic Insights into the Degradation of Resistant Starch by Human Gut Microbiota.
    Vital M; Howe A; Bergeron N; Krauss RM; Jansson JK; Tiedje JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30266729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
    Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
    Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a homogeneous polysaccharide from Sijunzi decoction on human intestinal microbes and short chain fatty acids in vitro.
    Gao B; Wang R; Peng Y; Li X
    J Ethnopharmacol; 2018 Oct; 224():465-473. PubMed ID: 29890316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease.
    Emoto T; Yamashita T; Kobayashi T; Sasaki N; Hirota Y; Hayashi T; So A; Kasahara K; Yodoi K; Matsumoto T; Mizoguchi T; Ogawa W; Hirata KI
    Heart Vessels; 2017 Jan; 32(1):39-46. PubMed ID: 27125213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects.
    Martínez I; Kim J; Duffy PR; Schlegel VL; Walter J
    PLoS One; 2010 Nov; 5(11):e15046. PubMed ID: 21151493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effect of lotus seed resistant starch and short-chain fatty acids on mice fecal microbiota in vitro.
    Li X; Lei S; Liu L; Zhang Y; Zheng B; Zeng H
    Int J Biol Macromol; 2021 Jul; 183():2272-2281. PubMed ID: 34097970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community.
    Zhao C; Hu Y; Chen H; Li B; Cao L; Xia J; Yin Y
    PLoS One; 2020; 15(3):e0230200. PubMed ID: 32214324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial.
    Becker A; Schmartz GP; Gröger L; Grammes N; Galata V; Philippeit H; Weiland J; Ludwig N; Meese E; Tierling S; Walter J; Schwiertz A; Spiegel J; Wagenpfeil G; Faßbender K; Keller A; Unger MM
    Genomics Proteomics Bioinformatics; 2022 Apr; 20(2):274-287. PubMed ID: 34839011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte Very Long-Chain Saturated Fatty Acids, Gut Microbiota-Bile Acid Axis, and Incident Coronary Artery Disease in Adults: A Prospective Cohort Study.
    Xie K; Xiao C; Lin L; Li F; Hu W; Yang Y; Chen D; Miao Z; Sun TY; Yan Y; Zheng JS; Chen YM
    J Nutr; 2024 Oct; 154(10):3019-3030. PubMed ID: 39128547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease.
    Ottosson F; Brunkwall L; Smith E; Orho-Melander M; Nilsson PM; Fernandez C; Melander O
    J Hypertens; 2020 Dec; 38(12):2427-2434. PubMed ID: 32665522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistant starch intake alleviates collagen-induced arthritis in mice by modulating gut microbiota and promoting concomitant propionate production.
    Bai Y; Li Y; Marion T; Tong Y; Zaiss MM; Tang Z; Zhang Q; Liu Y; Luo Y
    J Autoimmun; 2021 Jan; 116():102564. PubMed ID: 33203617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistant Starch is Actively Fermented by Infant Faecal Microbiota and Increases Microbial Diversity.
    Gopalsamy G; Mortimer E; Greenfield P; Bird AR; Young GP; Christophersen CT
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31208010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical Inaccessibility of a Resistant Starch Shifts Mouse Gut Microbiota to Butyrogenic Firmicutes.
    Kaur A; Chen T; Green SJ; Mutlu E; Martin BR; Rumpagaporn P; Patterson JA; Keshavarzian A; Hamaker BR
    Mol Nutr Food Res; 2019 Apr; 63(7):e1801012. PubMed ID: 30659764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
    Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
    FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial.
    Zhang L; Ouyang Y; Li H; Shen L; Ni Y; Fang Q; Wu G; Qian L; Xiao Y; Zhang J; Yin P; Panagiotou G; Xu G; Ye J; Jia W
    Sci Rep; 2019 Mar; 9(1):4736. PubMed ID: 30894560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice.
    Smith BJ; Miller RA; Ericsson AC; Harrison DC; Strong R; Schmidt TM
    BMC Microbiol; 2019 Jun; 19(1):130. PubMed ID: 31195972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
    Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
    Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.